Bella Kaufman

37.8k total citations · 5 hit papers
250 papers, 15.2k citations indexed

About

Bella Kaufman is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bella Kaufman has authored 250 papers receiving a total of 15.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 69 papers in Genetics and 66 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bella Kaufman's work include BRCA gene mutations in cancer (56 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (43 papers). Bella Kaufman is often cited by papers focused on BRCA gene mutations in cancer (56 papers), Cancer Treatment and Pharmacology (45 papers) and Advanced Breast Cancer Therapies (43 papers). Bella Kaufman collaborates with scholars based in Israel, United States and United Kingdom. Bella Kaufman's co-authors include Mario Campone, Raphael Catane, Eric C. Rackow, Jay L. Falk, Ido Wolf, Arlene Chan, Stephen D. Rubin, Tadeusz Pieńkowski, Cristina Oliva and Charles E. Geyer and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Bella Kaufman

242 papers receiving 14.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

2006 2.5k citations Tadeusz Pieńkowski, Arlene Chan et al. New England Journal of Medicine profile →
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

2019 1.6k citations Fabrice André, Eva Ciruelos et al. New England Journal of Medicine profile →
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

2014 1.2k citations Bella Kaufman, Michael Friedländer et al. Journal of Clinical Oncology profile →
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

2009 596 citations Bella Kaufman, Andrew Wardley et al. Journal of Clinical Oncology profile →
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

2020 371 citations Fabrice André, Dejan Juric et al. profile →

Peers

Countries citing papers authored by Bella Kaufman

Since Specialization

Citations

This map shows the geographic impact of Bella Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bella Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bella Kaufman more than expected).

Fields of papers citing papers by Bella Kaufman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bella Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bella Kaufman. The network helps show where Bella Kaufman may publish in the future.

Co-authorship network of co-authors of Bella Kaufman

This figure shows the co-authorship network connecting the top 25 collaborators of Bella Kaufman. A scholar is included among the top collaborators of Bella Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bella Kaufman. Bella Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Applying Ultrasound to Mechanically and Noninvasively Sensitize Prostate Tumors to TRAIL‐Mediated Apoptosis 2025 ·Advanced Science ·(unknown), (unknown), Jenna A. Dombroski, (unknown), (unknown), Jiro Kusunose, Katherine N. Gibson‐Corley, Bella Kaufman, (unknown), Charles F. Caskey, Michael R. King	2
2	Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects 2022 ·PLoS neglected tropical diseases ·Michael V. Callahan, Anthony M. Treston, Grace Lin, (unknown), Bella Kaufman, Mansoora Khaliq, Lisa Evans DeWald, Kevin B. Spurgers, Kelly L. Warfield, (unknown), (unknown), Aruna Sampath, Urban Ramstedt	19
3	A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B 2022 ·Journal of Clinical Investigation ·Nicole Muschol, (unknown), (unknown), İlyas Okur, Fatih Süheyl Ezgü, Paul Harmatz, (unknown), María L. Couce, Shuan‐Pei Lin, Spyros Batzios, Maureen Cleary, (unknown), Igor Nestrašil, Bella Kaufman, Adam J. Shaywitz, Stephen M. Maricich, (unknown), Joseph Kovalchin, Eric Zanelli	9
4	Iatrogenic haemoperitoneum requiring transfusion after ventriculoperitoneal shunt placement: case report 2020 ·British Journal of Neurosurgery ·Aneek Patel, Danielle Golub, (unknown), Bella Kaufman	1
5	Proteomic patterns associated with response to breast cancer neoadjuvant treatment 2020 ·Molecular Systems Biology ·Anjana Shenoy, Nishanth Belugali Nataraj, Gili Perry, Fabricio Loayza‐Puch, Remco Nagel, (unknown), (unknown), Noa Bossel Ben‐Moshe, (unknown), Iris Barshack, Bella Kaufman, Reuven Agami, Yosef Yarden, Maya Dadiani, Tamar Geiger	38
6	ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis 2020 ·Breast Cancer Research ·Adi Zundelevich, Maya Dadiani, (unknown), (unknown), Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, (unknown), Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam	67
7	Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer breakdown → 2019 ·New England Journal of Medicine ·Fabrice André, Eva Ciruelos, Gábor Rubovszky, Mario Campone, Sibylle Loibl, Hope S. Rugo, Hiroji Iwata, Pierfranco Conté, Ingrid A. Mayer, Bella Kaufman, Toshinari Yamashita, Yen‐Shen Lu, Kenichi Inoue, Masato Takahashi, Zsuzsanna Pápai, (unknown), David Mills, Celine Wilke, Samit Hirawat, Dejan Juric	1565
8	Abstract PD6-11: An open-label, multitumor, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated (g BRCA m) HER2-negative metastatic breast cancer (MBC) 2018 ·Cancer Research ·S. M. Domchek, Sophie Postel‐Vinay, Y-J. Bang, YH Park, Jérôme Alexandre, J.P. Delord, Antoîne Italiano, Benoît You, Susan E.P. Bastian, Matthew Krebs, Dawei Wang, Saiama N. Waqar, Helen K. Angell, Maria Learoyd, Shan‐Chwen Chang, Christopher Gresty, Pia Herbolsheimer, Bella Kaufman	41
9	The Effect of Reflexology on the Pain-Insomnia-Fatigue Disturbance Cluster of Breast Cancer Patients During Adjuvant Radiation Therapy 2017 ·The Journal of Alternative and Complementary Medicine ·Ricardo Tarrasch, Narin N. Carmel Neiderman, (unknown), Bella Kaufman, (unknown), Merav Ben‐David, Dorit Gamus	31
10	Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer 2016 ·Clinical Cancer Research ·Maya Dadiani, Noa Bossel Ben‐Moshe, Shani Paluch–Shimon, Gili Perry, (unknown), (unknown), (unknown), (unknown), (unknown), Ady Yosepovich, Einav Nili Gal‐Yam, Raanan Berger, Iris Barshack, Eytan Domany, Bella Kaufman	7
11	Fluid Resuscitation in Circulatory Shock 2015 ·Current studies in hematology and blood transfusion ·Bella Kaufman, Eric C. Rackow, Jay L. Falk	1
12	Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses 2014 ·British Journal of Cancer ·Thomas Brodowicz, István Láng, Zsuzsanna Kahán, Richard Greil, S. Beslija, Salomon M. Stemmer, Bella Kaufman, Luboš Petruželka, Alexandru Eniu, (unknown), Krassimir Koynov, D. Vrbanec, Tadeusz Pieńkowski, Bohuslav Melichar, S. Špánik, (unknown), Diethelm Messinger, Moshe Inbar, Christoph Zielinski	24
13	Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer 2013 ·Journal of Clinical Oncology ·José Baselga, Patricia Gómez, Richard Greil, Sofía Braga, Miguel Ángel Climent, Andrew Wardley, Bella Kaufman, Salomon M. Stemmer, António Pêgo, Arlene Chan, J. Goeminne, Marie-Pascale Graas, Megan Kennedy, Eva María Ciruelos Gil, Andreas Schneeweiß, Angela Zubel, Jutta Groos, Helena Melezínková, Ahmad Awada	298
14	Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer 2011 ·Journal of Clinical Oncology ·Stan B. Kaye, Jan Lubiński, Ursula A. Matulonis, Joo Ern Ang, Charlie Gourley, Beth Y. Karlan, Amnon Amit, Katherine M. Bell‐McGuinn, Lee-may Chen, Michael Friedländer, Tamar Safra, Ignace Vergote, Mark Wickens, Elizabeth Lowe, James Carmichael, Bella Kaufman	378
15	KL1 Internal Repeat Mediates Klotho Tumor Suppressor Activities and Inhibits bFGF and IGF-I Signaling in Pancreatic Cancer 2011 ·Clinical Cancer Research ·Lilach Abramovitz, Tamar Rubinek, Hagai Ligumsky, Shikha Bose, Iris Barshack, Camila Avivi, Bella Kaufman, Ido Wolf	107
16	Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy 2008 ·Journal of Clinical Oncology ·Stephen Johnston, Maureen Trudeau, Bella Kaufman, Hamouda Boussen, (unknown), Patricia LoRusso, Donald P. Lombardi, Slim Ben Ahmed, Dennis L. Citrin, Michelle DeSilvio, Jennifer L. Harris, Ron E. Westlund, Vanessa Salazar, Tal Zaks, Neil L. Spector	152
17	The P1812A and P25T BRCA1 and the 5164del4 BRCA2 Mutations: Occurrence in High-Risk Non-Ashkenazi Jews 2006 ·Genetic Testing ·Bella Kaufman, Yael Laitman, Marcelo A. Carvalho, (unknown), (unknown), Jamal Zidan, Álvaro N.A. Monteiro, Eitan Friedman	6
18	Complications arising from the use of ophthalmologic medications in an intensive care unit patient. 1989 ·PubMed ·(unknown), Bella Kaufman	2
19	Treatment of Defects of the Anterior Abdominal Wall in Newborns 1983 ·Mayo Clinic Proceedings ·Lisa A. Smith, Robert L. Telander, Donald R. Cooney, B. Dawson, Fredric Kleinberg, Bella Kaufman	3
20	[EXPEDITIONS IN THE STUDY OF THE EPIDEMIOLOGY OF CANCER IN THE USSR]. 1964 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Bella Kaufman, (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact